$4.7 Billion Flow Cytometry Market - Global Forecast to 2022

Dublin, Feb. 27, 2018 (GLOBE NEWSWIRE) -- The "Flow Cytometry Market by Technology (Cell & Bead-based), Product & Services (Analyzer, Sorter, Reagents), Application (Research (Cell Analysis), Clinical (Cancer, HIV)), End User (Academia, Research Institute, Hospital) - Global Forecast to 2022" report has been added to ResearchAndMarkets.com's offering.

The global flow cytometry market is expected to reach USD 4.79 Billion by 2022 from USD 3.29 Billion in 2017, growing at a CAGR of 7.8% during 2017-2022.

Factors such as the attributed to factors such as the continuous technological advancements in the field of flow cytometry, increasing incidence and prevalence of target diseases (such as HIV/AIDS and cancer), growing adoption of flow cytometry in advanced research activities and clinical trials, and increasing availability of novel application-specific flow cytometry products are driving the growth of the global market.

Geographically, this market is classified into North America, Europe, Asia Pacific, and the Rest of the World. In 2017, the global market is expected to be dominated by North America, followed by Europe. However, the Asia Pacific region is expected to witness the fastest growth during the forecast period owing to the increasing participation of China, India, Japan, and South Korea in flow cytometry-based research; expansion of research infrastructure; and increasing public-private initiative aimed towards boosting advance research practices in this region.

The growth of flow cytometry market mainly restrained by factors such as the high cost of flow cytometry instruments and a dearth of skilled professionals and insufficient knowledge regarding the use of flow cytometers.

Product launches and enhancements are the key growth strategies adopted by major players to strengthen their position in the global market. In addition, strategies such as partnerships and collaborations; acquisitions; and expansions were also adopted by several market players to strengthen their market position, expand their R&D capabilities, and geographic presence in the global flow cytometry market.

As of 2016, BD (US), Beckman Coulter (US), and Thermo Fisher Scientific (US), Merck KGaA (Germany), Sysmex Partec (Germany), Luminex Corporation (US), Miltenyi Biotec (Germany), Bio-Rad Laboratories (US), Sony Biotechnology (US), Agilent Technologies (US), ACEA Biosciences (US), biomrieux (France), Enzo Life Sciences (US), Stratedigm (US), and Apogee Flow Systems (UK), were some of the key players operating in the global flow cytometry market.

Key Topics Covered:

1 Introduction
1.1 Objectives of the Study
1.2 Definition
1.3 Study Scope
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology
2.1 Research Data
2.2 Market Size Estimation
2.3 Data Triangulation Methodology
2.4 Assumptions for the Study

3 Executive Summary

4 Premium Insights
4.1 Flow Cytometry Market: Overview
4.2 Flow Cytometry Products & Services Market, 2017 vs 2022
4.3 Global Market, By Technology (USD Million)
4.4 Flow Cytometry Market, By Products & Services, 2017-2022 (USD Million)
4.5 Global Market, By Application (USD Million)
4.6 Flow Cytometry Market, By End User, 2017 vs 2022
4.7 Geographical Snapshot of the Global Market

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Technological Advancements in Flow Cytometers
5.2.1.2 Growing Adoption of Flow Cytometry Techniques in Research Activities and Clinical Trials
5.2.1.3 Growing Incidence and Prevalence of HIV/AIDS and Cancer
5.2.1.4 Increasing Availability of Novel Application-Specific Flow Cytometry Products
5.2.2 Restraints
5.2.2.1 High Cost of Flow Cytometry Instruments
5.2.2.2 Dearth of Skilled Professionals and Insufficient Knowledge Regarding the Use of Flow Cytometers
5.2.3 Opportunities
5.2.3.1 Growing Market Penetration in Emerging Countries
5.2.3.2 Growth in Stem Cell Research
5.2.3.3 Evolution of High-Throughput Flow Cytometry Technology
5.2.4 Challenges
5.2.4.1 Inadequate Infrastructure for Research in Emerging Countries
5.2.4.2 Complexities Related to Reagent Development
5.3 Regulatory Challenges
5.3.1 Challenging Fda Requirements
5.3.2 Stringent Analyte-Specific Reagent (ASR) Rule
5.3.3 Validation Challenges for Cell-Based Instruments
5.3.4 Absence of Established Laboratory-Developed Test (LDT) Guidelines on Cell-Based Fluorescence Assays
5.3.5 Changing Regulatory Environment
5.4 Reimbursement Scenario

6 Flow Cytometry Market, By Technology
6.1 Introduction
6.2 Cell-Based Flow Cytometry
6.3 Bead-Based Flow Cytometry

7 Flow Cytometry Market, By Product & Service
7.1 Introduction
7.1.1 Reagents and Consumables
7.1.2 Flow Cytometry Instruments
7.1.2.1 Cell Analyzers
7.1.2.1.1 Cell Analyzers Market, By Price Range
7.1.2.1.1.1 High-Range Cell Analyzers
7.1.2.1.1.2 Mid-Range Cell Analyzers
7.1.2.1.1.3 Low-Range Cell Analyzers
7.1.2.2 Cell Sorters
7.1.2.2.1 Cell Sorters Market, By Price Range
7.1.2.2.1.1 High-Range Cell Sorters
7.1.2.2.1.2 Mid-Range Cell Sorters
7.1.2.2.1.3 Low-Range Cell Sorters
7.1.3 Services
7.1.4 Software
7.1.5 Accessories

8 Global Flow Cytometry Market, By Application
8.1 Introduction
8.2 Research Applications
8.2.1 Pharmaceutical and Biotechnology
8.2.1.1 Drug Discovery
8.2.1.2 Stem Cell Research
8.2.1.3 In Vitro Toxicity Testing
8.2.2 Immunology
8.2.3 Cell Sorting
8.2.4 Apoptosis
8.2.5 Cell Cycle Analysis
8.2.6 Cell Viability
8.2.7 Cell Counting
8.2.8 Other Research Applications
8.3 Clinical Applications
8.3.1 Cancer
8.3.2 Hematology
8.3.3 Immunodeficiency Diseases
8.3.4 Organ Transplantation
8.3.5 Other Clinical Applications
8.4 Industrial Applications

9 Flow Cytometry Market, By End User
9.1 Introduction
9.2 Academic & Research Institutes
9.3 Hospitals & Clinical Testing Laboratories
9.4 Pharmaceutical & Biotechnology Companies

10 Global Flow Cytometry Market, By Region

11 Competitive Landscape
11.1 Overview
11.2 Market Share Analysis
11.3 Competitive Scenario

12 Company Profiles
12.1 Introduction
12.2 Becton, Dickinson and Company
12.3 Beckman Coulter (A Subsidiary of Danaher)
12.4 Thermo Fisher Scientific
12.5 Merck KGaA
12.6 Bio-Rad Laboratories
12.7 Miltenyi Biotec
12.8 Sysmex Partec (A Subsidiary of Sysmex Corporation)
12.9 Luminex
12.10 Sony Biotechnology (A Wholly Owned Subsidiary of Sony Corporation)
12.11 Agilent Technologies
12.12 Acea Biosciences
12.13 Biomrieux S.A.
12.14 Enzo Life Sciences (A Wholly Owned Subsidiary of Enzo Biochem, Inc.)
12.15 Stratedigm
12.16 Apogee Flow Systems

For more information about this report visit https://www.researchandmarkets.com/research/mpb5dz/4_7_billion_flow?w=12

                    
                    
                    CONTACT: ResearchAndMarkets.com
                             Laura Wood, Senior Manager
                             press@researchandmarkets.com
                             For E.S.T Office Hours Call 1-917-300-0470
                             For U.S./CAN Toll Free Call 1-800-526-8630
                             For GMT Office Hours Call +353-1-416-8900
                             Related Topics: Biotechnology